Variation in Pediatric Asthmonia Diagnosis and Outcomes among Hospitalized Children

JoAnna K Leyenaar1, Meng-Shiou Shieh2, Penelope S Pekow2,3

  • 1Department of Pediatrics, Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Insights

Pediatric asthma-pneumonia co-diagnoses, or asthmonia, vary widely by hospital. High asthmonia rates are linked to increased antibiotic use, longer hospital stays, and higher costs, especially in smaller, rural hospitals.

Area of Science:

  • Pediatric Pulmonology
  • Healthcare Quality Improvement
  • Infectious Disease Epidemiology

Background:

  • The co-diagnosis of asthma exacerbation and pneumonia (
  • asthmonia
  • ) in children is common, despite radiographic confirmation in <5% of cases.
  • High rates of asthmonia diagnosis may lead to unnecessary healthcare costs and antibiotic overprescribing.

Purpose of the Study:

  • To analyze hospital-level variations in pediatric asthmonia diagnosis rates.
  • To investigate the association between hospital asthmonia diagnosis rates and clinical outcomes.

Main Methods:

  • Cross-sectional analysis of 274 hospitals using the Premier Healthcare Database (10/1/2015–6/30/2018).
  • Included children and adolescents (2-17 years) hospitalized with asthma exacerbation.
  • Calculated risk-standardized asthmonia rates using hierarchical generalized linear models and analyzed associations with hospital characteristics and clinical outcomes.

Main Results:

  • Of 24,606 asthma exacerbations, 21.1% received an asthma-pneumonia co-diagnosis.
  • Median risk-adjusted asthmonia rate was 20.9%, with significant hospital variation (range 8.4–55.9%).
  • Hospitals with high asthmonia rates were smaller, nonteaching, rural facilities with less subspecialty support, and showed increased antibiotic use, longer stays, and higher costs.

Conclusions:

  • Significant variation in pediatric asthmonia diagnosis rates exists, with hospital of admission being a key predictor.
  • Efforts to reduce unwarranted asthmonia diagnoses are crucial, particularly in resource-limited rural hospitals.
  • Addressing diagnostic variation can optimize antibiotic stewardship and healthcare resource utilization.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
963
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K